Search

everythinglearnresearchcommunity

for

Search:↓

Herbal solution improves hair diameter and density more than 5% minoxidil for androgenetic alopecia.

New grading scale accurately measures hair loss severity and treatment effectiveness.

JetPeel-assisted minoxidil improves hair density and thickness more than minoxidil alone.

Hair restoration combines drugs and follicular unit grafting for natural, long-lasting results.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Mutation in hairless gene may increase hair loss risk.

New oral treatment, finasteride, effectively and safely treats common hair loss.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Better hair loss models needed for research.

Hair transplants for male baldness can show inflammation and fibrosis, but more research is needed to confirm LPP presence.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

People with male pattern baldness are more likely to have metabolic syndrome.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Mesenchymal stem cell-derived exosomes significantly increase hair density and thickness in androgenic alopecia patients.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Beard hair can be used for hair transplants in severe alopecia cases, with minimal complications and good results.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.

Minoxidil and photobiomodulation together improve hair growth better than minoxidil alone.

Finasteride may effectively treat hair loss in Klinefelter Syndrome patients.

Platelet Rich Plasma (PRP) treatment effectively reduces hair fall and increases hair growth in patients with Androgenetic Alopecia (AGA), but it may cause pain.